0001740380-20-000002.txt : 20201230
0001740380-20-000002.hdr.sgml : 20201230
20201230113316
ACCESSION NUMBER: 0001740380-20-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201230
DATE AS OF CHANGE: 20201230
EFFECTIVENESS DATE: 20201230
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CiVi Biopharma Holdings, Inc.
CENTRAL INDEX KEY: 0001740380
IRS NUMBER: 824833651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-384757
FILM NUMBER: 201424674
BUSINESS ADDRESS:
STREET 1: ONE TOWN PLACE, SUITE 200
CITY: BRYN MAWR
STATE: PA
ZIP: 19010
BUSINESS PHONE: 484-222-6251
MAIL ADDRESS:
STREET 1: ONE TOWN PLACE, SUITE 200
CITY: BRYN MAWR
STATE: PA
ZIP: 19010
D
1
primary_doc.xml
X0708
D
LIVE
0001740380
CiVi Biopharma Holdings, Inc.
5425 Wisconsin Ave.
Chevy Chase
MD
MARYLAND
20815
301.968.2392
DELAWARE
None
None
Corporation
true
2017
Henrik
Oerum
c/o CiVi Biopharma Holdings, Inc.
5425 Wisconsin Ave.
Chevy Chase
MD
MARYLAND
20815
Director
Shalom
Jacobovitz
c/o CiVi Biopharma Holdings, Inc.
5425 Wisconsin Ave.
Chevy Chase
MD
MARYLAND
20815
Executive Officer
Director
Aaron
Davis
c/o CiVi Biopharma Holdings, Inc.
5425 Wisconsin Ave.
Chevy Chase
MD
MARYLAND
20815
Director
Christopher
Fuglesang
c/o CiVi Biopharma Holdings, Inc.
Chevy Chase
MD
MARYLAND
20815
Director
Carole
Nuechterlein
c/o CiVi Biopharma Holdings, Inc.
Chevy Chase
MD
MARYLAND
20815
Director
Matthew
Pietras
c/o CiVi Biopharma Holdings, Inc.
5425 Wisconsin Ave.
Chevy Chase
MD
MARYLAND
20815
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2020-11-18
false
true
true
Preferred Stock can convert to underlying shares of Common Stock.
false
0
27456172
27456172
0
A portion of the proceeds were satisfied by cancellation of indebtedness.
false
9
0
0
0
false
CiVi Biopharma Holdings, Inc.
/s/ Shalom Jacobovitz
Shalom Jacobovitz
Chief Executive Officer
2020-12-15